The federal Food and Drug Administration approved Banner Pharmacaps, a High Point-based developer of soft gelatin capsules, abbreviated new drug application for the treatment of subarachnoid hemorrhage, a form of cerebral bleeding.
The company's Nimodipine 30 mg capsules are the AB-rated generic equivalent of Bayer's Nimotop 30 mg capsules. Banner has partnered with Heritage Pharmaceuticals of New Jersey to sell and market Nimodipine.